Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Role of inhibitory effect on reactive oxygen species formation
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 148 (4) , 611
- https://doi.org/10.1016/j.ahj.2004.05.014
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2αJournal of Biological Chemistry, 1995
- Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trialJournal of the American College of Cardiology, 1995
- Myocardial salvage: Its assessment and prediction by the analysis of serial myocardial contrast echocardiograms in patients with acute myocardial infarctionAmerican Heart Journal, 1994
- Does reperfusion injury exist in humans?Journal of the American College of Cardiology, 1993
- Failure of Chronic, High-dose, Oral Vitamin E Treatment to Protect the Ischemic, Reperfused Porcine HeartJournal of Molecular and Cellular Cardiology, 1993
- Nicorandil Attenuates Myocardial Dysfunction Associated with Transient Ischemia by Opening ATP-Dependent Potassium ChannelsJournal of Cardiovascular Pharmacology, 1992
- Therapeutic potential of vitamin E against myocardial ischemic-reperfusion injuryFree Radical Biology & Medicine, 1991
- Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjectsJournal of the American College of Cardiology, 1985
- Effects of Nicorandil and Nifedipine on Protection of Ischemic MyocardiumJournal of Cardiovascular Pharmacology, 1984